Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2011608.pdf
Reference44 articles.
1. Barker KT, Jackson LE, Crompton MR . (1997). BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 15: 799–805.
2. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ . (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274: 8335–8343.
3. Born M, Quintanilla-Fend L, Braselmann H, Reich U, Richter M, Hutzler P et al. (2005). Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J Pathol 205: 592–596.
4. Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH . (2004). Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol 24: 10558–10572.
5. Corkery B, Crown J, Clynes M, O'Donovan N . (2009). Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. Ann Oncol 20: 862–867.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential of targeting signal-transducing adaptor protein-2 in cancer therapeutic applications;Exploration of Targeted Anti-tumor Therapy;2024-03-07
2. The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms;Biomedicines;2024-02-19
3. An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC;International Journal of Molecular Sciences;2023-09-13
4. Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer;Cancers;2023-07-21
5. PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation;Cell Death & Disease;2023-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3